Dapsone Tablet
Product Images NDC 70771-1980

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 70771-1980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 01)

Dapsone Tablets, USP 25 mg oral tablet label from Zydus Lifesciences Limited. The label states the package contains 30 tablets and is Rx only. It includes storage instructions, dosage referencing accompanying literature, and child-resistant packaging information.*

FDA Label Image

100 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 02)

Label for Dapsone Tablets USP, 100 mg oral tablets, in a package containing 30 tablets. The label states the product is prescription only and child-resistant packaging instructions. It is manufactured by Zydus Pharmaceuticals Ltd. in Ahmedabad, India. Storage instructions and dosage guidance reference accompanying literature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.